Pneumonia — Written Clinical Reasoning

SAQ 1 — Severe CAP: Immediate Management, Empiric Therapy, and Corticosteroid Decision (20 marks, 30 minutes)

Prompt: Outline your immediate resuscitation and empiric antibiotic management of this patient. Include your ventilatory strategy, the specific drug regimens with doses, whether you would use adjunctive corticosteroids and why, and your plan for the right pleural effusion. Include the evidence base for each major decision. [1]

Model Answer

Immediate resuscitation and Sepsis Six (4 marks): [1]

This patient has severe CAP (CURB-65 = 5, PSI likely class V) with septic shock (hypotension, lactataemia, confusion) and type 1 respiratory failure. She meets IDSA/ATS major criteria for severe CAP (need for vasopressor support anticipated). My immediate priorities follow the Sepsis Six: [1]

1. High-flow oxygen via face mask targeting SpO2 94-98% (she does not have known CO2 retention, though COPD is a risk — I would check an arterial blood gas at 30-60 minutes and adjust the target to 88-92% if she is retaining CO2).
2. Take blood cultures (two sets), send lactate (already 3.2 — rising lactate confirms tissue hypoperfusion), and obtain a venous gas.
3. Administer broad-spectrum antibiotics within one hour — this is the single most time-critical intervention in septic shock.
4. Give intravenous crystalloid — 30 mL/kg of balanced crystalloid (Hartmann's or Plasma-Lyte) over the first 3 hours, then reassess fluid responsiveness.
5. Measure urine output — urinary catheter and hourly monitoring as a marker of perfusion.
6. Assess for vasopressor need — if she remains hypotensive after fluid resuscitation, start noradrenaline via a central line, titrated to MAP at least 65 mmHg. [1]

Empiric antibiotic therapy (5 marks): [1]

Given severe CAP in the ICU without current risk factors for Pseudomonas (no bronchiectasis, no recent hospitalisation, no known colonisation) or MRSA (not post-influenza, no cavitating infiltrates), I would prescribe: [1]

• Piperacillin-tazobactam 4.5 g IV every 8 hours (or ceftriaxone 2 g IV daily) — for pneumococcal, Haemophilus, and other typical bacterial cover, with the anti-pseudomonal breadth of pip-tazo as a prudent choice given her COPD and the severity
• PLUS azithromycin 500 mg IV daily — for atypical cover (Legionella, Mycoplasma, Chlamydia), which is mandatory in severe CAP [1]

The rationale for the beta-lactam plus macrolide combination is that observational data consistently show lower mortality with combination therapy than with beta-lactam monotherapy in severe CAP, attributable to the atypical cover and possibly the anti-inflammatory (immunomodulatory) effect of macrolides. The IDSA/ATS 2019 guideline mandates atypical cover in severe CAP [1].

I would also send pneumococcal and Legionella urinary antigens (rapid, high-yield in severe CAP), and sputum culture if obtainable. If the Legionella urinary antigen is positive, I would continue the macrolide and extend the duration to 5-10 days (azithromycin) or switch to a respiratory fluoroquinolone (moxifloxacin) for 14-21 days. [1]

Corticosteroid decision (4 marks): [1]

Yes — I would add adjunctive corticosteroids. The evidence supports their use in severe CAP: [1]

• The Blum et al. RCT (Lancet 2015) showed prednisone 50 mg orally daily for 7 days shortened time to clinical stability by approximately 1.5 days [4].
• The Siemieniuk et al. meta-analysis (Ann Intern Med 2015) showed corticosteroids reduced mortality (RR 0.67), mechanical ventilation (RR 0.45), and ARDS (RR 0.24) in severe CAP, with the benefit concentrated in the severe subgroup [3].

The main adverse effect is hyperglycaemia (RR 1.49), which is relevant given her type 2 diabetes — I would monitor blood glucose closely and may need an insulin sliding scale while she is on steroids. There was no increase in gastrointestinal haemorrhage or secondary infection in the meta-analysis. [1]

The regimen: prednisone 50 mg orally (or via nasogastric tube) daily for 7 days (or hydrocortisone 200 mg/day IV if unable to tolerate oral). I would not extend beyond 7 days unless there was a separate indication (e.g., refractory septic shock per the Surviving Sepsis guidelines, which use hydrocortisone 200 mg/day when vasopressors are ongoing). [1]

Parapneumonic effusion management (4 marks): [1]

Her right pleural effusion (25 mm on lateral decubitus) requires diagnostic thoracentesis because it is moderate in size and she has severe pneumonia — the effusion may already be complicated. I would: [1]

1. Perform a pleural ultrasound to characterise the effusion (size, loculation, echogenicity) and mark a safe site for aspiration.
2. Perform diagnostic thoracentesis, sending pleural fluid for pH (using a blood gas analyser), protein, LDH, glucose, cell count and differential, Gram stain, and culture.
3. Interpret using Light's criteria for exudate versus transudate, and the pH and glucose for the decision to drain:
   • pH over 7.20 and glucose over 3.3 mmol/L — uncomplicated; antibiotics alone
   • pH 7.0-7.20 or loculated — complicated parapneumonic effusion; chest drain plus antibiotics, consider intrapleural fibrinolytics (tPA/DNase) if loculated
   • pH under 7.0 or frank pus — empyema; chest drain plus fibrinolytics or surgical drainage (VATS) [1]

The key teaching point is that a patient with CAP who is not improving after 48-72 hours of appropriate antibiotics must be re-evaluated for a parapneumonic effusion or empyema — this is a common reason for treatment failure and must not be missed. [1]

Communication and follow-up (3 marks): [1]

• I would explain to the patient's family that she has severe pneumonia with sepsis, that she is being treated in the ICU, and that the first 48-72 hours are critical.
• Once she recovers, I would address smoking cessation (the single most effective intervention to reduce future CAP risk) with varenicline or nicotine replacement therapy.
• Arrange pneumococcal and influenza vaccination before discharge (after recovery from the acute illness, typically 2-4 weeks).
• Arrange a repeat CXR at 6 weeks to ensure radiographic resolution and exclude an underlying lesion (especially important in a 40 pack-year smoker — underlying bronchial obstruction from lung cancer can present as a non-resolving pneumonia). [1]

SAQ 2 — Investigation Interpretation and Severity Stratification (10 marks, 20 minutes)

Prompt: A 58-year-old hotel maintenance worker presents with a 3-day history of high fever (39.6 degrees C), dry cough, headache, confusion, watery diarrhoea, and myalgia. On examination: heart rate 88/min, blood pressure 110/70, respiratory rate 26/min, SpO2 90% on room air. Blood tests: sodium 126 mmol/L, ALT 110 U/L, CK 380 U/L, CRP 210 mg/L, urea 6.5 mmol/L. Chest X-ray shows patchy bilateral consolidation. Interpret the clinical syndrome, state your most likely diagnosis, and outline the specific investigations and empiric therapy you would initiate. [1]

Model Answer

Clinical syndrome interpretation (3 marks): [1]

This is a severe atypical pneumonia syndrome with prominent extrapulmonary features. The constellation of: [1]

• High fever with relative bradycardia (HR 88 for a temperature of 39.6)
• Confusion/encephalopathy
• Gastrointestinal symptoms (watery diarrhoea)
• Hyponatraemia (SIADH — sodium 126)
• Elevated transaminases and creatine kinase
• Bilateral patchy consolidation
• Occupational exposure (hotel maintenance — cooling tower/aerosolised water exposure) [1]

is the classic clinical pattern of Legionnaires' disease (Legionella pneumophila serogroup 1). The hyponatraemia, deranged LFTs, raised CK, GI symptoms, and neurological involvement together form a highly suggestive cluster. [1]

Her CURB-65 is 3 (Respiratory rate over 30 — actually 26 so this is absent; Confusion — present; age 58 — under 65; Urea under 7; BP normal). Recounting: Confusion (1), RR 26 (under 30, 0), Urea 6.5 (under 7, 0), BP 110/70 (normal, 0), age 58 (under 65, 0) — CURB-65 is 1 (confusion alone). However, despite the low CURB-65, the clinical severity (bilateral consolidation, hypoxia, extrapulmonary features) and the specific Legionella syndrome justify inpatient management and a high index of suspicion. [1]

Specific investigations (3 marks): [1]

1. Legionella urinary antigen — the highest-yield rapid test; detects serogroup 1 polysaccharide antigen with specificity over 95% and sensitivity approximately 70-80%. Results available within hours.
2. Pneumococcal urinary antigen — to exclude or identify co-existing pneumococcal infection.
3. Sputum culture on buffered charcoal yeast extract (BCYE) agar — Legionella does not grow on standard media; BCYE agar is required and takes 3-5 days. This confirms the diagnosis and allows serotyping.
4. Blood cultures — rarely positive in Legionella but important to exclude bacteraemic typical pneumonia.
5. Legionella serology (paired sera, 4-fold rise over 2-4 weeks) — retrospective confirmation.
6. Arterial blood gas — to assess oxygenation and ventilation; she is hypoxic (SpO2 90%).
7. Respiratory PCR panel — increasingly available and can detect Legionella, Mycoplasma, and other atypicals rapidly. [1]

Empiric therapy (4 marks): [1]

The empiric regimen must cover both typical and atypical pathogens until the Legionella diagnosis is confirmed: [1]

• Ceftriaxone 1-2 g IV daily (for pneumococcus and typical bacteria) PLUS azithromycin 500 mg IV or orally daily (for Legionella and other atypicals) [1]

The macrolide is essential because Legionella is an intracellular pathogen — it replicates inside alveolar macrophages, and only antibiotics that achieve high intracellular concentrations (macrolides and respiratory fluoroquinolones) are effective. Beta-lactams alone will not treat Legionella because they do not penetrate cells effectively. [1]

Once the Legionella urinary antigen is positive, I would:

• Continue azithromycin 500 mg daily for 5-10 days (or switch to a respiratory fluoroquinolone such as moxifloxacin 400 mg daily for 14-21 days if the disease is severe or the patient is immunocompromised — fluoroquinolones may be slightly more effective in severe Legionella).
• Stop the ceftriaxone if typical pathogens are excluded.
• Consider adjunctive corticosteroids (prednisone 50 mg daily for 7 days) given the severity (bilateral consolidation, hypoxia, confusion). [1]

Key examiner points: Legionella must be in the differential of any severe CAP with extrapulmonary features. The urinary antigen is rapid and high-yield. The antibiotic must be intracellular-active (macrolide or fluoroquinolone). Public health notification is required if Legionella is confirmed, to identify and decontaminate the source (cooling tower, spa, water system). [1]